Intraoperative Radiation Therapy Market to Expand at a Healthy Growth Rate in the Coming Years

The rising incidence of cancer, technological advancements such as the introduction of mobile IORT system, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market.

Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players.The Electron IORT segment to account for the largest share of the intraoperative radiation therapy market, by method, in 2019Download PDF Brochure@https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245000083Based on method, the intraoperative radiation therapy market is segmented into electron IORT and intraoperative brachytherapy.

The electron IORT segment is expected to account for the largest share of the intraoperative radiation therapy market in 2019.

The large share of this segment can be attributed to its advantages such as better depth dose distribution, low treatment time, and optimal dose homogeneity as compared to HDR-IORT or kV IORT.The other cancers segment, by application, is to register the highest CAGR in the intraoperative radiation therapy market during the forecast periodBased on application, the intraoperative radiation therapy market is segmented into breast cancer, brain tumor, gastrointestinal cancer, head & neck cancer, and other cancers.

The other cancer application segment includes penile cancer, lung cancer, childhood cancer, colorectal cancer, endometrial & cervical cancer, and prostate cancer.

This segment is expected to grow at the fastest CAGR owing to growing research activities in new application areas of the IORT market.North America to dominate the intraoperative radiation therapy market during the forecast periodRead More@https://www.marketsandmarkets.com/PressReleases/intraoperative-radiation-therapy.aspThe intraoperative radiation therapy market is segmented into four regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World.

The Superficial Radiation Therapy System Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.

This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.

The major players in the superficial radiation therapy system market include Sensus Healthcare, Xstrahl Limited and Others.

This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Superficial Radiation Therapy System Market Research Report" by requesting FREE Sample Copy athttps://www.valuemarketresearch.com/contact/superficial-radiation-therapy-system-market/download-sampleMarket DynamicsThe rising prevalence of skin cancer, across the globe, is primarily driving the market growth.

Superficial radiation therapy enables effective treatment with minimum postoperative complications is also boosting the market growth.

Along with this, ongoing R and rising efforts of major players for increasing the production capacity is expected to create potential demand over the forecast period.The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis.

This study involved the extensive use of both primary and secondary sources.

The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

[159 Pages Report] The global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period.The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market.

Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players.Market DynamicsGrowing global prevalence of cancerImproving reimbursement scenarioProcedural advantages over EBRTTechnological advancementsCOVID-19 Impact on the global Intraoperative radiation therapy marketThe intraoperative radiation therapy market was significantly impacted by the COVID-19 pandemic.

Various screening, diagnostic, and surgical procedures were restricted or postponed at hospitals and cancer treatment centers, which resulted in disruptions in the cancer diagnosis as well as treatment market.

Major regulatory authorities across the globe, such as the CDC, WHO, MHRA, TGA, and EMA, have identified cancer patients at a greater risk of contracting coronavirus disease than healthy adults.

Orbisreserach.Com adds “Global Intraoperative Radiation Therapy Systems Market” To Its Research Database.Description:                             This report studies the global market size of Intraoperative Radiation Therapy Systems in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intraoperative Radiation Therapy Systems in these regions.

This report also studies the global Intraoperative Radiation Therapy Systems market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

Request a sample of this report @ http://orbisresearch.com/contacts/request-sample/2293847 The following manufacturers are covered in this report, with sales, revenue, market share for each company: IntraOp Medical Carl Zeiss Meditec AG iCAD Market size by Product Breast Cancer Head & Neck Tumors Spinal Metastases Brain Tumors Gastrointestinal Tumors Skin Cancer Others Market size by End User Ambulatory & Surgical Centers Hospitals Specialty Clinics OthersIf enquiry before buying this report @ http://orbisresearch.com/contacts/enquiry-before-buying/2293847 The study objectives of this report are: To study and analyze the global Intraoperative Radiation Therapy Systems market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Intraoperative Radiation Therapy Systems are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units).

Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research.

The relatively new technology for integrating magnetic resonance imaging (MRI) with radiation therapy is becoming increasingly prevalent, with revenues from the MRI-guided radiation therapy systems market exceeding US$ 220 Mn in 2018, according to a recent study by Fact.MR.

This remarkable growth potential of the MRI-guided radiation therapy systems market can be attributed to burgeoning adoption of innovative technologies in the cancer diagnosis & treatment, alongside growing focus on patient-centric care.Request for the Report Summary: https://www.factmr.com/report/2572/mri-guided-radiation-therapy-system-marketThe study assesses macro and microeconomic factors that define the growth prospects of the MRI-guided radiation therapy systems market.

It finds that leading players in the rapidly-growing healthcare sector are vying for new techniques in cancer treatment to compensate for involuntary patient movements and improve precision to a much higher degree.

In addition, the paradigm shift in preference of cancer patients towards radiation therapies, from invasive to non-invasive procedures, is expected to remain instrumental in adoption of MRI-guided radiation therapy systems in cancer care.The study opines that hospital, with over 51% revenue share, will remain the target customer for players in the MRI-guided radiation therapy systems market in 2019.

Opportunities abound for of MRI-guided radiation therapy system developers,, with ongoing clinical development of high-tech procedures exploiting Linac MR-RT (Linear accelerators integrated with magnetic resonance radiotherapy).Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S_id=2572The study also finds that radiotherapy centers are adopting technologically-advanced MRI-compatible radiation models, to explore numerous possibilities to make radiotherapy treatment more effective.

Market players are focusing on building a successful consortium with the help of physicians, clinicians, as well as Original Equipment Manufacturers (OEMs), to tap opportunities in the radiation therapy centers.The study opines that the increasing healthcare expenditure in the United States (U.S.) will remain a key growth determinant of the MRI-guided radiation therapy systems market in North America.